GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds Bookmark CommentsGo to comments Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who dont use the medications, researchers said Monday
Long-term metabolic health is shaped by a broader ecosystem of habits: Nutrition Dietary patterns that emphasize: Whole foods Adequate protein intake Controlled energy balance Physical Activity Regular movement supports: Insulin sensitivity Muscle preservation Energy expenditure Sleep Poor sleep has been linked to increased appetite hormones and metabolic dysfunction
It is the first FDA-approved oral GLP-1 medication for weight management and offers a needle-free option backed by clinical data
The body evolved during periods of food scarcity and interprets significant caloric reduction as famine
I have a couple of pairs of jeans that fit great, but otherwise I'm in my mom uniform, and I'm not stressed about it at all
Ussar, S., Bezy, O., Blher, M